Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Vanderbilt

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
JCO Precision Oncology|October 7, 2024
Response to Crizotinib After Entrectinib Resistance in <i>ROS1</i>-Rearranged, <i>MET</i>-Amplified Lung AdenocarcinomaVictor R Vaz, Malini M Gandhi, Biagio Ricciuti, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2020
Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing ResultsAmir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, et al.
The Journal of Molecular Diagnostics : JMD|November 21, 2021
Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation SequencingKseniya Petrova-Drus, Andrés E Quesada, Anita S Bowman, et al.
Nature Communications|April 16, 2025
A clinical benchmark of public self-supervised pathology foundation modelsGabriele Campanella, Shengjia Chen, Manbir Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2023
Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy ResponseIsrael S Kasago, Walid K Chatila, Cecilia M Lezcano, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
Nature Communications|January 2, 2025
A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencingJohn Ziegler, Jaclyn F Hechtman, Satshil Rana, et al.
Blood Advances|June 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implantsPaola Ghione, Diana Mandelker, Maria E Arcila, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Acta Neuropathologica|October 13, 2023
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomasRichard A Hickman, Erika Gedvilaite, Ryan Ptashkin, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|October 7, 2024
Response to Crizotinib After Entrectinib Resistance in <i>ROS1</i>-Rearranged, <i>MET</i>-Amplified Lung AdenocarcinomaVictor R Vaz, Malini M Gandhi, Biagio Ricciuti, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2020
Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing ResultsAmir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, et al.
The Journal of Molecular Diagnostics : JMD|November 21, 2021
Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation SequencingKseniya Petrova-Drus, Andrés E Quesada, Anita S Bowman, et al.
Nature Communications|April 16, 2025
A clinical benchmark of public self-supervised pathology foundation modelsGabriele Campanella, Shengjia Chen, Manbir Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2023
Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy ResponseIsrael S Kasago, Walid K Chatila, Cecilia M Lezcano, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
Nature Communications|January 2, 2025
A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencingJohn Ziegler, Jaclyn F Hechtman, Satshil Rana, et al.
Blood Advances|June 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implantsPaola Ghione, Diana Mandelker, Maria E Arcila, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Acta Neuropathologica|October 13, 2023
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomasRichard A Hickman, Erika Gedvilaite, Ryan Ptashkin, et al.
Pageof 6